Top

Gepubliceerd in:

01-09-2014

Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates

Auteurs: Kristi Reynolds, Hema N. Viswanathan, Paul Muntner, Teresa N. Harrison, T. Craig Cheetham, Jin-Wen Y. Hsu, Deborah T. Gold, Stuart Silverman, Andreas Grauer, Donald E. Morisky, Cynthia D. O’Malley

Gepubliceerd in: Quality of Life Research | Uitgave 7/2014

Abstract

Purpose

To examine the psychometric properties and validity of the 8-item Osteoporosis-Specific Morisky Medication Adherence Scale (OS-MMAS-8) in postmenopausal women prescribed bisphosphonates (BPs) for at least 15 months.

Methods

A random sample of women aged ≥55 years with osteoporosis prescribed daily or weekly BPs was identified. Pharmacy fill data were extracted to calculate the medication possession ratio (MPR). Eligible women were stratified by low (<0.50), medium (0.50–0.79), or high (≥0.80) MPR, with the a priori goal of recruiting 133 participants in each group. OS-MMAS-8 scores can range from 0 to 8 and were categorized as low (<6), medium (6 to <8), and high (8) adherence. Internal consistency reliability (Cronbach’s alpha), test–retest reliability [intraclass correlation coefficients (ICCs)] and convergent validity (correlating OS-MMAS-8 with MPR and other self-reported measures) were assessed.

Results

A total of 400 women out of 449 respondents reported that they were still taking their BPs at the time of the survey and completed OS-MMAS-8. Overall, 38.5, 34.3, and 27.3 % of participants had low, medium, and high OS-MMAS-8 scores, respectively. The mean (SD) MPRs according to OS-MMAS-8 scores (<6, 6 to <8 and 8) were 56.9 (22.6), 69.0 (24.9), and 76.7 (26.4), respectively. The correlation between OS-MMAS-8 and MPR was 0.36; p < 0.0001. Cronbach’s alpha was 0.74, and the ICC was 0.83 (95 % CI 0.76–0.88).

Conclusions

OS-MMAS-8 has acceptable psychometric properties for assessing medication adherence in postmenopausal women prescribed therapy for osteoporosis. Additional studies are needed to investigate the psychometric properties of OS-MMAS-8 in other settings and populations.

vorige artikel Translation, cross-cultural adaptation and validation of the Bulgarian version of the Dizziness Handicap Inventory

volgende artikel Health-related quality of life in young adults in education, employment, or training: development of the Japanese version of Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales Young Adult Version

Alleen toegankelijk voor geautoriseerde gebruikers

National Osteoporosis Foundation. (2013). What is osteoporosis? Retrieved June 19, 2013, from http://www.nof.org/articles/7.

Rosen, C. J. (2005). Clinical practice. Postmenopausal osteoporosis. The New England Journal of Medicine, 353(6), 595–603.PubMedCrossRef

Watts, N. B., Bilezikian, J. P., Camacho, P. M., Greenspan, S. L., Harris, S. T., Hodgson, S. F., et al. (2010). American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis: Executive summary of recommendations. Endocrine Practice, 16(6), 1016–1019.PubMedCrossRef

Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., et al. (2007). Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. The New England Journal of Medicine, 356(18), 1809–1822.PubMedCrossRef

Halpern, R., Becker, L., Iqbal, S. U., Kazis, L. E., Macarios, D., & Badamgarav, E. (2011). The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: A retrospective claims analysis of female health plan enrollees with osteoporosis. Journal of Managed Care Pharmacy, 17(1), 25–39.PubMed

Siris, E. S., Selby, P. L., Saag, K. G., Borgstrom, F., Herings, R. M., & Silverman, S. L. (2009). Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. The American Journal of Medicine, 122(2 Suppl), S3–S13.PubMedCrossRef

Weycker, D., Macarios, D., Edelsberg, J., & Oster, G. (2007). Compliance with osteoporosis drug therapy and risk of fracture. Osteoporosis International, 18(3), 271–277.PubMedCrossRef

Kothawala, P., Badamgarav, E., Ryu, S., Miller, R. M., & Halbert, R. J. (2007). Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clinic Proceedings, 82(12), 1493–1501.PubMedCrossRef

Weycker, D., Macarios, D., Edelsberg, J., & Oster, G. (2006). Compliance with drug therapy for postmenopausal osteoporosis. Osteoporosis International, 17(11), 1645–1652.PubMedCrossRef

10.

Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353(5), 487–497.PubMedCrossRef

11.

Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006). Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures. The Annals of Pharmacotherapy, 40(7–8), 1280–1288.PubMedCrossRef

12.

Reynolds, K., Viswanathan, H. N., O’Malley, C. D., Muntner, P., Harrison, T. N., Cheetham, T. C., et al. (2012). Psychometric properties of the osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates. The Annals of Pharmacotherapy, 46(5), 659–670.PubMedCrossRef

13.

Koebnick, C., Langer-Gould, A. M., Gould, M. K., Chao, C. R., Iyer, R. L., Smith, N., et al. (2012). Sociodemographic characteristics of members of a large, integrated health care system: Comparison with US Census Bureau Data. The Permanente Journal, 16(3), 37–41.PubMedCentralPubMedCrossRef

14.

Sikka, R., Xia, F., & Aubert, R. E. (2005). Estimating medication persistency using administrative claims data. The American Journal of Managed Care, 11(7), 449–457.PubMed

15.

Steiner, J. F., & Prochazka, A. V. (1997). The assessment of refill compliance using pharmacy records: Methods, validity, and applications. Journal of Clinical Epidemiology, 50(1), 105–116.PubMedCrossRef

16.

Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 14, 1–24.CrossRef

17.

Risser, J., Jacobson, T. A., & Kripalani, S. (2007). Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. Journal of Nursing Measurement, 15(3), 203–219.PubMedCrossRef

18.

Dimenas, E., Glise, H., Hallerback, B., Hernqvist, H., Svedlund, J., & Wiklund, I. (1993). Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scandinavian Journal of Gastroenterology, 28(8), 681–687.PubMedCrossRef

19.

Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Brod, M., et al. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes, 2, 12.PubMedCentralPubMedCrossRef

20.

Ware, J., Jr, Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.PubMedCrossRef

21.

Krousel-Wood, M., Islam, T., Webber, L. S., Re, R. N., Morisky, D. E., & Muntner, P. (2009). New medication adherence scale versus pharmacy fill rates in seniors with hypertension. The American Journal of Managed Care, 15(1), 59–66.PubMedCentralPubMed

22.

Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension, 10(5), 348–354.PubMedCentralPubMedCrossRef

23.

Horne, R., Buick, D., Fisher, M., Leake, H., Cooper, V., & Weinman, J. (2004). Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART. International Journal of STD and AIDS, 15(1), 38–44.PubMedCrossRef

24.

Revicki, D. A., Wood, M., Wiklund, I., & Crawley, J. (1998). Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Quality of Life Research, 7(1), 75–83.PubMedCrossRef

25.

Cronbach, L. J. (1951). Coefficient alpha and internal structure tests. Psychometrika, 16, 297–334.CrossRef

26.

Nunnaly, J. (1978). Psychometric theory. New York: McGraw-Hill.

27.

Leidy, N. K., Revicki, D. A., & Geneste, B. (1999). Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value in Health, 2(2), 113–127.PubMedCrossRef

28.

Lin, L. I. (1989). A concordance correlation coefficient to evaluate reproducibility. Biometrics, 45(1), 255–268.PubMedCrossRef

29.

Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.PubMedCrossRef

30.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Lawrence Erlbaum.

31.

Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107(2), 238–246.PubMedCrossRef

32.

Browne, M., & Cudeck, R. (1992). Alternative ways of assessing model fit. Sociological Methods & Research, 21, 230–259.CrossRef

33.

Hatcher, L. (1994). A step-by-step approach to using the SAS system for factor analysis and structural equation modeling. Cary, NC: SAS Institute.

34.

Hu, L., & Bentler, P. M. (1998). Fit indices in covariance structure modeling: Sensitivity to underparameterized model misspecification. Psychological Methods, 3, 424–453.CrossRef

35.

Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009). Good and poor adherence: Optimal cut-point for adherence measures using administrative claims data. Current Medical Research and Opinion, 25(9), 2303–2310.PubMedCrossRef

36.

Breuil, V., Cortet, B., Cotte, F. E., Arnould, B., Dias-Barbosa, C., Gaudin, A. F., et al. (2012). Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporosis International, 23(2), 445–455.PubMedCentralPubMedCrossRef

37.

Haynes, R. B., Taylor, D. W., Sackett, D. L., Gibson, E. S., Bernholz, C. D., & Mukherjee, J. (1980). Can simple clinical measurements detect patient noncompliance? Hypertension, 2(6), 757–764.PubMedCrossRef

38.

Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in cardiovascular outcomes. Circulation, 119(23), 3028–3035.PubMedCrossRef

39.

DiMatteo, M. R. (2004). Variations in patients’ adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42(3), 200–209.PubMedCrossRef

40.

Curtis, J. R., Cai, Q., Wade, S. W., Stolshek, B. S., Adams, J. L., Balasubramanian, A., et al. (2013). Osteoporosis medication adherence: Physician perceptions vs. patients’ utilization. Bone, 55(1), 1–6.PubMedCentralPubMedCrossRef

Titel: Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates
Auteurs: Kristi Reynolds
Hema N. Viswanathan
Paul Muntner
Teresa N. Harrison
T. Craig Cheetham
Jin-Wen Y. Hsu
Deborah T. Gold
Stuart Silverman
Andreas Grauer
Donald E. Morisky
Cynthia D. O’Malley
Publicatiedatum: 01-09-2014
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 7/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-014-0662-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2014

Sensory impairments and their associations with functional disability in a sample of the oldest-old

On the associations between physical activity and quality of life: findings from an Australian nationally representative panel survey

The level of agreement between child self-reports and parent proxy-reports of health-related quality of life in boys with Duchenne muscular dystrophy

Differential item functioning in the Observer Scale of the POSAS for different scar types

Translation, cross-cultural adaptation and validation of the Bulgarian version of the Dizziness Handicap Inventory

Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update